Access Statistics for Toshiaki Iizuka

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are Quality-Adjusted Medical Prices Declining for Chronic Disease? Evidence from Diabetes Care in Four Health Systems 0 0 0 54 0 0 0 44
Asymmetric Demand Response when Prices Increase and Decrease: The Case of Child Healthcare 0 1 3 16 1 3 9 39
Asymmetric Demand Response when Prices Increase and Decrease: The Case of Child Healthcare 1 1 2 10 1 1 4 36
Drug Advertising and Health Habit 0 0 1 70 0 0 1 414
False Alarm? Estimating the Marginal Value of Health Signals 0 0 0 49 0 0 0 57
Free for Children? Patient Cost-sharing and Healthcare Utilization 0 0 0 18 3 3 7 83
Free for Children? Patient Cost-sharing and Healthcare Utilization 0 0 2 27 1 2 6 46
Is Zero a Special Price? Evidence from Child Healthcare 0 0 6 31 0 1 26 89
Long-term Care in Japan 0 2 17 17 4 6 22 22
Promoting Innovation in Small Markets: Evidence from the market for rare and intractable diseases 0 0 0 24 0 0 4 37
Robots and Labor in the Service Sector: Evidence from Nursing Homes 0 1 6 56 0 2 16 106
Total Working Papers 1 5 37 372 10 18 95 973


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
An Empirical Analysis of Planned Obsolescence 0 1 4 70 0 2 8 240
Are quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems 0 0 0 1 0 0 1 23
Cartel sustainability in retail markets: Evidence from a health service sector 0 1 1 19 1 2 2 115
Comment on “How does the Price Regulation Policy Impact on Patient–Nurse Ratios and the Length of Hospital Stays in Japanese Hospitals?” 0 0 0 1 0 0 0 20
Comment on “Sustainable Health Financing for COVID‐19 Preparedness and Response in Asia and the Pacific” 0 0 0 4 0 0 0 6
DIRECT TO CONSUMER ADVERTISING AND PRESCRIPTION CHOICE 0 1 5 78 0 1 12 232
DURABLE GOODS PRICE CYCLES: THEORY AND EVIDENCE FROM THE TEXTBOOK MARKET 0 0 0 9 0 1 2 61
Does Higher Malpractice Pressure Deter Medical Errors? 0 0 2 35 1 2 5 139
Experts' agency problems: evidence from the prescription drug market in Japan 2 2 5 32 7 7 15 127
False alarm? Estimating the marginal value of health signals 1 1 1 5 3 4 6 49
GENERIC ENTRY IN A REGULATED PHARMACEUTICAL MARKET* 0 0 0 34 0 0 1 117
Patient cost sharing and medical expenditures for the Elderly 0 0 2 21 0 0 5 113
Physician Agency and Adoption of Generic Pharmaceuticals 0 0 0 58 1 4 6 272
Promoting innovation in small markets: Evidence from the market for rare and intractable diseases 0 0 1 3 0 0 1 28
The Effect of Prescription Drug Advertising on Doctor Visits 0 1 3 80 0 1 3 317
The Impact of Physician Supply on the Healthcare System: Evidence from Japan's New Residency Program 0 0 2 10 0 0 2 33
The generic drug market in Japan: will it finally take off? 0 0 0 31 0 0 0 91
What Explains the Use of Direct‐to‐Consumer Advertising of Prescription Drugs? 0 0 0 118 0 0 0 424
Total Journal Articles 3 7 26 609 13 24 69 2,407


Statistics updated 2024-06-06